ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS

Technology
E-221-2015
Patent ID
E-221-2015-0-US-03
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
10548987
Publication Number
US-2018-0214568-A1
Application Number
15/747,620
IC
NCI
Date Filed
Date Issued